Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan.

AmVac AG is a biopharmaceutical company with a clear strategic focus on the development and subsequent commercialization of innovative immune therapies and prophylactic vaccines. The head office of the company is in Zug, Switzerland. Creating new therapies for the indication areas gynecology, urology and respiratory diseases are at the core of AmVac's strategy.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Founded in 2015 in Palo Alto, California, USA, I Peace, Inc. is a leading CDMO (contract development and manufacturing organization) of clinical-grade cell products. The founder and CEO Dr. Koji Tanabe earned his doctorate at Kyoto University under Nobel laureate Dr. Shinya Yamanaka and was the second author of the groundbreaking article on the development of human iPSCs. I Peace’s mission is to ease the suffering of diseased patients and help healthy people maintain a high quality of life. With its proprietary manufacturing platform that enables parallel production of discrete iPSCs from multiple donors in a single room, I Peace can provide a large volume of high-quality clinical-grade iPSCs at competitive cost. Our goal is to create custom iPSCs for every individual to become their stem cells for life while supporting drug and cell therapy companies to accelerate their development to make cell therapy an affordable option.

Part of ISHIHARA SANGYO KAISHA LTD., GenomIdea, Inc. is a Japanese company located in Ibaraki. The firm engages in biopharmaceutical products development and distribution. On January 31, 2013 ISHIHARA SANGYO KAISHA LTD. acquired GenomIdea, Inc. from AnGes, Inc.

Hayashibara Biochemical Laboratories, Inc. manufactures food and cosmetic products. It also makes health food ingredients, functional dyes, and reagents. The company was founded in 1970 and is headquartered in Okayamashi, Japan.

Shanghai Public Health Clinical Center is a Chinese company located in Shanghai and ultimately controlled by the Government of China that operates hospital and provides education and training for disease control and prevention.

Institute of Laboratory Animal Science, a subsidiary of University of Zurich, is a Swiss company located in Schlieren that provides research, services and teaching in translational and basic research.

Beijing Huafukang Biotechnology Co., Ltd., established on 2008-10-22, Business scope includes technology development;technology transfer;Technical Services;technical consulting;Technical Training;experimental animals(Does not contain dogs)farming,Sales;Sales of experimental animal feed,medical instruments(Ι,Class II),Chemical Products(Free of Hazardous Chemicals),wooden product,metal products;Import and export,Technology Import and Export,Agent import and export;Processing experimental animal feed;Dedicated transport of goods(Refrigerated).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Dedicated transport of goods(Refrigerated)and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.

Kureha Corp. engages in the manufacture and sale of chemical products for pharmaceuticals, agrochemicals, and packaging materials. It operates through the following segments: Functional Products, Chemical Products, Resin Products, Construction-related Business, and Others. The Functional Products segment produces Polyphenylene Sulfide (PPS) resin, Polyvinylidene Fluoride, and carbon products. The Chemical Products segment develops and markets industrial chemicals, pharmaceutical products, and pesticides. The Resin Products segment includes food packaging materials and household goods. The Construction-related Business segment deals with construction and engineering services. The Others segment covers environmental-related businesses and logistics. The company was founded on June 21, 1944 and is headquartered in Tokyo, Japan.

Versitech Ltd. is a Hong Kong Chinese company located in Hong Kong and ultimately controlled by the Government of Hong Kong Special Administrative Region. The firm provides business services.

Nihon Shokuhin Kako Co., Ltd. engages in the manufacture and sale of processed corn products. It offers food-grade materials, including starch, glycated products, and dietary fiber; industrial materials; fine chemicals, such as cyclodextrin, Japanese pharmacopoeia products, and diagnostic medical substrates; by-products comprising corn salad oils; corn steep liquor; and glue ten meals. The company was founded on July 26, 1948 and is headquartered in Tokyo, Japan.

JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following segments: Pharmaceutical Business; and Medical and Research Equipment Business. The Pharmaceutical Business segment deals with the manufacture, purchase, and sale of ethical drugs, active pharmaceutical ingredients, and raw materials. The Medical and Research Equipment Business segment sells medical devices and laboratory equipment. The company was founded by Shin Ashida on September 13, 1975 and is headquartered in Ashiya, Japan.

Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.

The Jewish General Hospital (JGH; French: Hôpital général juif), known officially as the Sir Mortimer B. Davis Jewish General Hospital (French: Hôpital général juif Sir Mortimer B. Davis) since 1978, is an acute-care teaching hospital in Montreal, Quebec, Canada. Affiliated with McGill University, it has 637 beds.

KBIC offers a platform of networking for about businesses and institutes in their pursuit of innovative collaboration and groundbreaking discoveries in a wide spectrum of medical, pharmaceutical, and biological fields, including the medical device and regenerative medical fields. KBIC’s foremost mission is to enhance human health and vitalize the global healthcare industry through collaborative ties between and among those in the business, academic, governmental and healthcare sectors.

Elixirgen Scientific, launched in 2016, is a Baltimore-based biotechnology company focused on stem cell related technology. The company’s mission is to make stem cell innovation available to everyone. The industry’s top issue is the high cost and and inefficiencies in iterating research and development due to the long cell differentiation period from human pluripotent stem cells to specific human cells. The company is now providing reagents, kits, and services at an affordable price to help make research and other laboratory work more efficient. Elixirgen Scientific, LLC is located in the Science + Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Scientific’s scientists to conduct research at state-of-the-art facilities.